Kaival Brands Innovations Group, Inc. (KAVL) Stock Price & Analysis
Kaival Brands Innovations Group, Inc. (KAVL) fell 18.52% to USD 0.02 as of July 25, 2026 at 03:53 UTC, according to Nexqual real-time market data.
KAVL last closed at USD 0.03; the session ranged USD 0.02–0.02 on volume of 1,691 shares. Market capitalization is $429,778, with a 52-week range of USD 0.01–1.16 (OQB). Source: Nexqual, July 25, 2026 at 03:53 UTC.
Key Statistics (as of July 25, 2026 at 03:53 UTC)
| Price | USD 0.02 |
|---|---|
| Change | ▼ 18.52% (down) |
| Previous Close | USD 0.03 |
| Open | USD 0.02 |
| Day Range | USD 0.02 – 0.02 |
| 52-Week Range | USD 0.01 – 1.16 |
| Volume | 1,691 shares |
| Market Cap | $429,778 |
| Exchange | OQB |
Technical Analysis (KAVL)
Nexqual's technical model rates KAVL "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 03:53 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 41.23 (neutral) |
| vs SMA50 | Below (USD 0.04) |
| MACD | -0 (negative) |
Analyst Ratings (KAVL)
Wall Street analysts rate KAVL "None", per Nexqual as of July 25, 2026 at 03:53 UTC.
| Consensus Rating | None |
|---|
Earnings (KAVL)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2023-07-31 | USD -0.63 vs est -1.05 ▲ beat |
| 2023-04-30 | USD -1.47 vs est -0.21 ▼ miss |
| 2023-01-31 | USD -1.05 vs est -1.05 ▲ beat |
Source: Nexqual, July 25, 2026 at 03:53 UTC.
Financials & Fundamentals (KAVL)
| Total Revenue | $365,481 |
|---|---|
| Revenue Growth (YoY) | -20.20% |
| Gross Margin | +100.00% |
| Operating Margin | -1530.89% |
| Profit Margin | +0.00% |
| ROE | -221.56% |
| Current Ratio | 0.95 |
| Total Cash | $277,951 |
| Total Debt | $0 |
| Free Cash Flow | $-1.13M |
Source: Nexqual, July 25, 2026 at 03:53 UTC.
Financial Health Score (KAVL)
Nexqual rates Kaival Brands Innovations Group, Inc.'s overall financial health "Weak" across five dimensions, as of July 25, 2026 at 03:53 UTC.
| Growth | Mixed — Revenue +2.6% YoY (annual), slow |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $278K cash, no debt |
| Cash Flow | Weak — FCF negative: -$1M, burning cash |
| Efficiency | Critical — ROE -222%, ROA -19.1% |
Ownership (KAVL)
| Insider Ownership | +15.39% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 19.54M |
| Float | 13.53M |
| Short % of Float | +0.97% |
Source: Nexqual, July 25, 2026 at 03:53 UTC.
Leadership (KAVL)
Kaival Brands Innovations Group, Inc. is led by Eric Mosser (age 46), CEO & Director, per Nexqual as of July 25, 2026 at 03:53 UTC.
| CEO & Director | Eric Mosser (age 46) |
|---|---|
| CFO & Director | Eric Morris (age 48) |
Major Backers & Investors (KAVL)
Notable institutional backers of Kaival Brands Innovations Group, Inc. include Two Sigma Investments, LP, according to Nexqual as of July 25, 2026 at 03:53 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Two Sigma Investments, LP | 0.24% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 0.35% |
Source: Nexqual, July 25, 2026 at 03:53 UTC.
From Kaival Brands Innovations Group, Inc.'s Latest SEC 10-K Filing (filed 2026-01-29)
Partnerships
- The par value per share of the Common Stock was not affected by the 2024 Reverse Stock Split.   Bidi Debt Exchange Agreement   On October 25, 2024 we entered the Debt Exchange Agreement with Bidi pursuant to which we satisfied an outstanding debt of $1,275,000 we owed to Bidi under the A&R Distribution Agreement by the issuance of 1,400,144 shares of our common stock to Bidi.   9    
- Our current primary source of revenue is through an international licensing agreement with Philip Morris Products S.A. ("PMPSA"), a wholly owned affiliate of Philip Morris International Inc. ("PMI").
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SMFL | Smart for Life, Inc. | USD 0 | ▲ 0% |
| ENSC | Ensysce Biosciences, Inc. | USD 0.26 | ▼ 7.96% |
| DBGI | Digital Brands Group, Inc. | USD 12.9 | ▼ 35.63% |
| AREB | American Rebel Holdings, Inc. | USD 0.22 | ▲ 27.98% |
| REVB | Revelation Biosciences, Inc. | USD 1.06 | ▼ 7.83% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:53 UTC. This page is informational and not investment advice.